A Study to Evaluate the Effectiveness, Pharmacokinetics, Safety, and Acceptability of Sayana Press When Injected Every Four Months

Trial Profile

A Study to Evaluate the Effectiveness, Pharmacokinetics, Safety, and Acceptability of Sayana Press When Injected Every Four Months

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 19 May 2017

At a glance

  • Drugs Medroxyprogesterone (Primary)
  • Indications Pregnancy
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 May 2017 New trial record
    • 17 May 2017 Planned End Date has been changed from 30 Apr 2021 to 30 Jul 2020.
    • 17 May 2017 Planned Primary Completion Date changed from 30 Apr 2020 to 30 Jul 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top